JCR

Modalis and JCR Pharmaceuticals enter into joint research agreement

Retrieved on: 
Tuesday, December 12, 2023

Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) today announced that it has entered into a joint research agreement with JCR Pharmaceuticals Co., Ltd. (JCR Pharmaceuticals) on joint evaluation of the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target.

Key Points: 
  • Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) today announced that it has entered into a joint research agreement with JCR Pharmaceuticals Co., Ltd. (JCR Pharmaceuticals) on joint evaluation of the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target.
  • Taking this agreement as an opportunity, Modalis and JCR Pharmaceuticals aim to establish the new gene therapies for undisclosed CNS diseases by applying J-Brain Cargo®, JCR Pharmaceuticals’ proprietary technology for crossing the blood-brain barrier (BBB), and CRISPR-GNDM® (Guide Nucleotide-Directed Modulation), Modalis proprietary epigenome modulation technology which does not require DNA cleavage.
  • Therefore, this joint research is an important step to explore the application of J-Brain Cargo®, with the aim of establishing new gene therapies in combination with CRISPR-GNDM®.
  • Haru Morita, CEO of Modalis, stated: “JCR Pharmaceuticals’ proprietary BBB penetrating technology, J-Brain Cargo®, has successfully and efficiently delivered biopharmaceutical candidates of various modalities to the CNS.

Canadian Solar Successfully Issues a JPY 18.5 Billion Green Samurai Private Placement in Japan

Retrieved on: 
Tuesday, October 17, 2023

GUELPH, ON, Oct. 17, 2023 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) today announced the successful placement of a JPY 18.5 billion green samurai private placement ("private placement").

Key Points: 
  • GUELPH, ON, Oct. 17, 2023 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) today announced the successful placement of a JPY 18.5 billion green samurai private placement ("private placement").
  • The private placement has a 3-year tenor with a mix of both semi-annual fixed (1.82% p.a.)
  • Canadian Solar has been a seasoned project bond issuer in Japan and had closed seven transactions for its ground mounted solar projects totaling over forty billion Japanese yen since 2016.
  • We look forward to continuing to partner with Canadian Solar in its quest to create a more sustainable planet for future generations."

Turkiye Garanti Bankasi A.S.: Announcement regarding JCR Credit Rating

Retrieved on: 
Friday, September 29, 2023

JCR Eurasia Rating, has evaluated the consolidated structure of “Türkiye Garanti Bankası A.Ş.” (the “Bank”) in the highest investment level category, affirmed the Long-Term National Issuer Credit Rating at ‘AAA (tr)’ and the Short-Term National Issuer Credit Rating at ‘J1+ (tr)’ with ‘Stable’ outlooks on 28 September 2023.

Key Points: 
  • JCR Eurasia Rating, has evaluated the consolidated structure of “Türkiye Garanti Bankası A.Ş.” (the “Bank”) in the highest investment level category, affirmed the Long-Term National Issuer Credit Rating at ‘AAA (tr)’ and the Short-Term National Issuer Credit Rating at ‘J1+ (tr)’ with ‘Stable’ outlooks on 28 September 2023.
  • On the other hand, the Long-Term International Foreign and Local Currency Issuer Credit Ratings have been affirmed at ‘BBB-’ and ‘BBB’ respectively, with ‘Stable’ outlooks, positioned above the country ceiling.
  • The Bank’s current ratings are as follows:

Wolters Kluwer delivers strong Lippincott journal performance in 2023 Journal Citation Reports

Retrieved on: 
Wednesday, August 9, 2023

Wolters Kluwer Health today announced strong results for the Lippincott portfolio of journals in the 2022 Journal Impact Factor (JIF), the journal metric released annually by Clarivate Analytics as part of the Journal Citation Reports (JCR).

Key Points: 
  • Wolters Kluwer Health today announced strong results for the Lippincott portfolio of journals in the 2022 Journal Impact Factor (JIF), the journal metric released annually by Clarivate Analytics as part of the Journal Citation Reports (JCR).
  • The 2023 rankings featured 387 Wolters Kluwer journals, with more than half (52%) receiving improved rankings from the previous year and an overall net increase for the portfolio.
  • To learn more about the titles within the Wolters Kluwer Lippincott publishing lineup, please visit lww.com .
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Human Factors and Ergonomics Society's Human Factors Journal Receives Prestigious Recognition

Retrieved on: 
Tuesday, July 18, 2023

The Human Factors and Ergonomics Society ( HFES ), the world’s largest scientific association for human factors/ergonomics professionals, announced that the society’s journal, Human Factors, achieved its second-highest rating at 3.3 from the annual Journal Citation Reports (JCR) published by Clarivate.

Key Points: 
  • The Human Factors and Ergonomics Society ( HFES ), the world’s largest scientific association for human factors/ergonomics professionals, announced that the society’s journal, Human Factors, achieved its second-highest rating at 3.3 from the annual Journal Citation Reports (JCR) published by Clarivate.
  • First published in 1958, Human Factors is the flagship journal of the Human Factors and Ergonomics Society, covering a wide variety of topics, including automation, human systems integration, industrial engineering, robotics and more.
  • Editor-in-Chief of Human Factors, Rob Radwin, said, “It’s encouraging that the journal has maintained its strong level of impact this year, the new method of calculating impact factors notwithstanding.” The publication looks forward to cultivating further innovations, celebrating the accomplishments and implementing forward steps to improving human factors and ergonomics research and practice.
  • For more details and additional information on the latest findings in human factors/ergonomics research and practice, please visit Human Factors and Ergonomic Society’s Journals and Proceedings website page.

Gemcorp, Africa Finance Corporation and Afreximbank announce the financial close of Cabinda Oil Refinery with a US$335-million project financing facility

Retrieved on: 
Thursday, July 13, 2023

LONDON and CAIRO, Egypt and LAGOS, Nigeria, July 13, 2023 (GLOBE NEWSWIRE) -- Gemcorp Holdings Limited (GHL), Africa Finance Corporation (AFC) and African Export-Import Bank (Afreximbank) are pleased to announce the financial close of the Cabinda Oil Refinery in Angola.

Key Points: 
  • LONDON and CAIRO, Egypt and LAGOS, Nigeria, July 13, 2023 (GLOBE NEWSWIRE) -- Gemcorp Holdings Limited (GHL), Africa Finance Corporation (AFC) and African Export-Import Bank (Afreximbank) are pleased to announce the financial close of the Cabinda Oil Refinery in Angola.
  • Other lenders also contributing to the project financing facility include The Industrial Development Corporation (IDC) of South Africa, The Arab Bank for the Economic Development in Africa (BADEA) and Banco de Fomento Angola (BFA).
  • Gemcorp Chief Executive Officer, Atanas Bostandjiev said, “We are extremely excited to be making this investment in the Cabinda Oil Refinery.
  • Africa Finance Corporation (AFC) was established in 2007 to be the catalyst for private sector-led infrastructure investment across Africa.

ESR Debuts in JPY Bond Markets with a JPY30 billion Dual-Tranche Transaction

Retrieved on: 
Friday, June 30, 2023

The gross proceeds of the Notes Issue will be JPY30 billion.

Key Points: 
  • The gross proceeds of the Notes Issue will be JPY30 billion.
  • SMBC Nikko Capital Markets Limited was mandated as the Sole Global Coordinator, and a Joint Bookrunner with MUFG Securities Asia Limited Singapore Branch.
  • The Group has an extensive AUM of US$35.1 billion in Japan and approximately 4.7 million sqm of GFA as of 31 December 2022.
  • ESR has US$1.8 billion in cash and a healthy gearing[2] of 22.8% as of 31 December 2022.

Clarivate Unveils Journal Citation Reports 2023 - a Trusted Resource to Support Research Integrity and Promote Accurate Journal Evaluation

Retrieved on: 
Wednesday, June 28, 2023

LONDON, June 28, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released the 2023 update to its annual Journal Citation Reports™ (JCR)™. This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines. Only journals that have met the rigorous quality standards for inclusion in the Web of Science™ index are selected, to ensure that users can confidently rely on the information and data provided to foster and support collective community goals to adhere to research integrity norms.

Key Points: 
  • This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines.
  • For nearly half a century, the information released in the annual Journal Citation Reports has been trusted by the global academic community as a reliable resource for identifying leading journals in their fields.
  • It provides clarity of key citation impact trends, powered by a range of indicators, descriptive data and compelling visualizations, enabling meaningful comparisons and insights.
  • The annual reports incorporate a variety of metrics, including the widely recognized Journal Impact Factor™ (JIF)™ and the Journal Citation Indicator.

Clarivate Unveils Journal Citation Reports 2023 - a Trusted Resource to Support Research Integrity and Promote Accurate Journal Evaluation

Retrieved on: 
Wednesday, June 28, 2023

LONDON, June 28, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released the 2023 update to its annual Journal Citation Reports™ (JCR)™. This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines. Only journals that have met the rigorous quality standards for inclusion in the Web of Science™ index are selected, to ensure that users can confidently rely on the information and data provided to foster and support collective community goals to adhere to research integrity norms.

Key Points: 
  • This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines.
  • For nearly half a century, the information released in the annual Journal Citation Reports has been trusted by the global academic community as a reliable resource for identifying leading journals in their fields.
  • It provides clarity of key citation impact trends, powered by a range of indicators, descriptive data and compelling visualizations, enabling meaningful comparisons and insights.
  • The annual reports incorporate a variety of metrics, including the widely recognized Journal Impact Factor™ (JIF)™ and the Journal Citation Indicator.

S&P upgrades CAF's rating to AA, its highest rating in its history

Retrieved on: 
Monday, May 29, 2023

"The upgrade is based on our expectation that CAF will continue to strengthen its position in Latin America and the Caribbean, thanks to its most recent capital increase.

Key Points: 
  • "The upgrade is based on our expectation that CAF will continue to strengthen its position in Latin America and the Caribbean, thanks to its most recent capital increase.
  • CAF's executive president, Sergio Diaz-Granados, noted: "We continue to consolidate the financial strength of Latin America's main asset, which is CAF.
  • In its report, S&P highlighted the institution's financial strength reflected in its liquidity levels, as well as its robust and diversified funding profile.
  • In addition, it expects CAF's capital position to remain resilient despite vulnerabilities in the region, as balance sheet growth will be accompanied by paid-in capital.